Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
Clinical trial NCT02760615 · WITHDRAWN
Trial details
- NCT number
- NCT02760615
- Sponsor
- Takeda
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2020-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.